PrecisemAb Biotech Co., Ltd.
- Biotech or pharma, therapeutic R&D
PrecisemAb Universal Antibody Lock is leveraged to develop disease-directed antibody therapy with higher safety and efficacy to solve systemic toxicity.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}